Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcesscell projection assembly

TBC1D19 DYNC2H1 ICAM1 TOGARAM1 STIL RCC2 TBC1D10B MTOR TMEM231 CFAP44 SCIN DNAH5 PCM1 JHY

6.96e-0668510214GO:0030031
GeneOntologyBiologicalProcessorganelle assembly

MYBPH TBC1D19 DYNC2H1 OBSCN TOGARAM1 STIL MAPRE3 TBC1D10B TIMP2 TRAPPC12 MTOR EIF5B TMEM231 CFAP44 DNAH5 TRIM37 PCM1 JHY

1.08e-05113810218GO:0070925
GeneOntologyBiologicalProcessregulation of cellular component biogenesis

TBC1D19 FNIP2 ICAM1 TOGARAM1 STIL ADGRE2 RCC2 ADD3 MAPRE3 TBC1D10B TIMP2 TRAPPC12 MTOR SEC16A SYK SCIN TRIM37 BAIAP2L2

1.95e-05118910218GO:0044087
GeneOntologyBiologicalProcesscilium organization

TBC1D19 DYNC2H1 TOGARAM1 STIL TBC1D10B TTC17 TMEM231 CFAP44 DNAH5 PCM1 JHY

2.37e-0547610211GO:0044782
GeneOntologyBiologicalProcessplasma membrane bounded cell projection assembly

TBC1D19 DYNC2H1 ICAM1 TOGARAM1 STIL RCC2 TBC1D10B MTOR TMEM231 CFAP44 DNAH5 PCM1 JHY

2.62e-0567010213GO:0120031
GeneOntologyBiologicalProcessregulation of protein-containing complex assembly

FNIP2 ICAM1 TOGARAM1 ADD3 MAPRE3 TRAPPC12 MTOR SEC16A SYK SCIN BAIAP2L2

3.04e-0548910211GO:0043254
GeneOntologyBiologicalProcesspositive regulation of protein kinase activity

ERBB2 FLT1 STIL MAPRE3 MTOR STRADA SYK PIH1D1 XRCC6

6.03e-053501029GO:0045860
GeneOntologyBiologicalProcesscilium assembly

TBC1D19 DYNC2H1 TOGARAM1 STIL TBC1D10B TMEM231 CFAP44 DNAH5 PCM1 JHY

7.04e-0544410210GO:0060271
GeneOntologyBiologicalProcesspositive regulation of cytoskeleton organization

ICAM1 TOGARAM1 STIL ADD3 MTOR SCIN BAIAP2L2

7.19e-052051027GO:0051495
GeneOntologyBiologicalProcessregulation of protein polymerization

ICAM1 TOGARAM1 ADD3 MAPRE3 MTOR SCIN BAIAP2L2

1.51e-042311027GO:0032271
GeneOntologyBiologicalProcesspositive regulation of kinase activity

ERBB2 FLT1 STIL MAPRE3 MTOR STRADA SYK PIH1D1 XRCC6

1.82e-044051029GO:0033674
GeneOntologyCellularComponentbrush border

SI ADD3 PROM1 CLIC1 MME SCIN

1.26e-041521066GO:0005903
GeneOntologyCellularComponentcluster of actin-based cell projections

SI ADD3 PROM1 CLIC1 MME SCIN USH2A

1.43e-042231067GO:0098862
GeneOntologyCellularComponentmyosin filament

MYBPH MYH13 OBSCN

2.69e-04251063GO:0032982
DomainFN3

MYBPH OBSCN LIFR PTPRB RIMBP3C RIMBP3B USH2A

8.91e-051851067SM00060
DomainFN3

MYBPH OBSCN LIFR PTPRB RIMBP3C RIMBP3B USH2A

1.40e-041991067PS50853
DomainFN3_dom

MYBPH OBSCN LIFR PTPRB RIMBP3C RIMBP3B USH2A

1.90e-042091067IPR003961
Domain-

MYBPH FLT1 PILRA ICAM1 OBSCN PLXND1 LIFR PTPRB RIMBP3C EXOC2 RIMBP3B USH2A

3.79e-04663106122.60.40.10
DomainIg-like_fold

MYBPH FLT1 PILRA ICAM1 OBSCN PLXND1 LIFR PTPRB RIMBP3C EXOC2 RIMBP3B USH2A

6.62e-0470610612IPR013783
DomainHEAT_REPEAT

TOGARAM1 HEATR5A BTAF1 MTOR

6.74e-04701064PS50077
DomainDHC_N1

DYNC2H1 DNAH5

8.74e-0481062PF08385
DomainDynein_heavy_dom-1

DYNC2H1 DNAH5

8.74e-0481062IPR013594
DomainPROTEIN_KINASE_TYR

ERBB2 FLT1 OBSCN SYK

2.27e-03971064PS00109
DomainTyr_kinase_AS

ERBB2 FLT1 OBSCN SYK

2.27e-03971064IPR008266
Domainfn3

MYBPH OBSCN LIFR PTPRB USH2A

2.31e-031621065PF00041
DomainTBC

TBC1D19 SGSM1 TBC1D10B

2.71e-03491063SM00164
DomainDynein_heavy_chain_D4_dom

DYNC2H1 DNAH5

2.78e-03141062IPR024317
DomainDynein_HC_stalk

DYNC2H1 DNAH5

2.78e-03141062IPR024743
DomainDynein_heavy_dom-2

DYNC2H1 DNAH5

2.78e-03141062IPR013602
DomainDHC_N2

DYNC2H1 DNAH5

2.78e-03141062PF08393
DomainATPase_dyneun-rel_AAA

DYNC2H1 DNAH5

2.78e-03141062IPR011704
DomainMT

DYNC2H1 DNAH5

2.78e-03141062PF12777
DomainAAA_8

DYNC2H1 DNAH5

2.78e-03141062PF12780
DomainAAA_5

DYNC2H1 DNAH5

2.78e-03141062PF07728
DomainDHC_fam

DYNC2H1 DNAH5

3.19e-03151062IPR026983
DomainDynein_heavy

DYNC2H1 DNAH5

3.19e-03151062PF03028
DomainDynein_heavy_dom

DYNC2H1 DNAH5

3.19e-03151062IPR004273
DomainRabGAP-TBC

TBC1D19 SGSM1 TBC1D10B

3.39e-03531063PF00566
DomainRab-GTPase-TBC_dom

TBC1D19 SGSM1 TBC1D10B

3.76e-03551063IPR000195
DomainTBC_RABGAP

TBC1D19 SGSM1 TBC1D10B

3.76e-03551063PS50086
DomainHEAT

TOGARAM1 BTAF1 MTOR

4.37e-03581063IPR000357
DomainRCC1

RCC2 HERC4

5.67e-03201062PF00415
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

DYNC2H1 ZNF329 NUP98 RTN3 MCM6 NOL10 RCC2 THADA SBNO1 CLIC1 GCLC MTOR EIF5B EEA1 FH DNAH5 XRCC6

1.46e-0614251061730948266
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

TBC1D19 ERBB2 SGSM1 AIMP2 TSHZ2 PTBP2 OBSCN RTN3 BTAF1 THADA PTPRB TIMP2 TTC17 MME ZSWIM4 KDM6A PCM1

2.63e-0614891061728611215
Pubmed

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.

ERBB2 DYNC2H1 DLGAP4 PCDHAC2 LGR4 BTAF1 PLXND1 THADA SARS2 GCLC SEC16A EEA1 FH EPCAM

4.33e-0610611061433845483
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

NUP98 DIDO1 MCM6 NOL10 RCC2 MTOR SEC16A EIF5B FH XRCC6 PCM1

5.21e-066531061122586326
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

NUP98 DIDO1 BTAF1 RCC2 ADD3 CLIC1 SEC16A EIF5B PIH1D1 SCIN HERC4 XRCC6 PCM1

5.54e-069341061333916271
Pubmed

HER2-mTOR signaling-driven breast cancer cells require ER-associated degradation to survive.

ERBB2 MTOR

9.20e-062106226012635
Pubmed

Elevated glucose represses lysosomal and mTOR-related genes in renal epithelial cells composed of progenitor CD133+ cells.

PROM1 MTOR

9.20e-062106233764985
Pubmed

Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses.

ICAM1 EPCAM

9.20e-062106234341066
Pubmed

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer.

ERBB2 EPCAM

9.20e-062106223519058
Pubmed

Chemical probing of HER2-amplified cancer cells identifies TORC2 as a particularly effective secondary target for combination with lapatinib.

ERBB2 MTOR

9.20e-062106226516700
Pubmed

CD133 affects the invasive ability of HCT116 cells by regulating TIMP-2.

PROM1 TIMP2

9.20e-062106223195431
Pubmed

Evaluation of HER2 expression in urothelial carcinoma cells as a biomarker for circulating tumor cells.

ERBB2 EPCAM

9.20e-062106232212383
Pubmed

Induction of ICAM1 in Brain Vessels is Implicated in an Early AD Pathogenesis by Modulating Neprilysin.

ICAM1 MME

9.20e-062106235948857
Pubmed

Syk is downstream of intercellular adhesion molecule-1 and mediates human rhinovirus activation of p38 MAPK in airway epithelial cells.

ICAM1 SYK

9.20e-062106217082600
Pubmed

Involvement of the Syk-mTOR pathway in follicular lymphoma cell invasion and angiogenesis.

MTOR SYK

9.20e-062106221926965
Pubmed

HER2-L755S mutation induces hyperactive MAPK and PI3K-mTOR signaling, leading to resistance to HER2 tyrosine kinase inhibitor treatment.

ERBB2 MTOR

9.20e-062106231135266
Pubmed

Prospectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells.

PROM1 MME

9.20e-062106220711432
Pubmed

Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei.

MUC16 EPCAM

9.20e-062106227038681
Pubmed

Cancer antigen-125 and ICAM-1 are together responsible for ascites in liver cirrhosis.

ICAM1 MUC16

9.20e-062106224779300
Pubmed

Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma.

PROM1 EPCAM

9.20e-062106226176038
Pubmed

Effect of adipocyte-secreted factors on EpCAM+/CD133+ hepatic stem cell population.

PROM1 EPCAM

9.20e-062106227131739
Pubmed

A new protocol for long-term culture of a specific subpopulation of liver cancer stem cells enriched by cell surface markers.

PROM1 EPCAM

9.20e-062106232662250
Pubmed

DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies.

PROM1 EPCAM

9.20e-062106228347289
Pubmed

Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: results of a companion protocol of the randomized, NOGGO-AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and paclitaxel containing sequential radiotherapy.

FLT1 TIMP2

9.20e-062106223415672
Pubmed

The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.

NUP98 DIDO1 SEC16A EIF5B PIH1D1 PCM1 WDR48

1.41e-05256106733397691
Pubmed

Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

FNIP2 STIM2 RCC2 POLR3E WDR48

1.65e-05103106510819331
Pubmed

CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.

DYNC2H1 ASCC1 MCM6 SARS2 SLC25A12 MTOR HLTF RARS2 EXOC2 XRCC6

1.70e-056061061036538041
Pubmed

Ggnbp2 Is Essential for Pregnancy Success via Regulation of Mouse Trophoblast Stem Cell Proliferation and Differentiation.

FLT1 LIFR MTOR EPCAM

1.82e-0551106426764350
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

STIM2 MYH13 NUP98 LGR4 MUC16 PLXND1 ADD3 THADA SEC16A PIH1D1 PCM1

2.61e-057771061135844135
Pubmed

Clinical evaluation of the simultaneous determination of CA 15-3, CA 125 and sHER2 in breast cancer.

ERBB2 MUC16

2.76e-053106217852076
Pubmed

MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.

MUC16 MTOR

2.76e-053106226046375
Pubmed

Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients.

ERBB2 MTOR

2.76e-053106229233126
Pubmed

Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways.

FLT1 MTOR

2.76e-053106216959214
Pubmed

Circular RNA circLIFR suppresses papillary thyroid cancer progression by modulating the miR-429/TIMP2 axis.

LIFR TIMP2

2.76e-053106238914806
Pubmed

VEGF attenuates lung injury by inducing homing of CD133+ progenitors via VEGFR1.

FLT1 PROM1

2.76e-053106230826058
Pubmed

Tyrosine phosphorylation of DEPTOR functions as a molecular switch to activate mTOR signaling.

MTOR SYK

2.76e-053106234634301
Pubmed

Complex N-glycan promotes CD133 mono-ubiquitination and secretion.

PROM1 EEA1

2.76e-053106230873590
Pubmed

HRV signaling in airway epithelial cells is regulated by ITAM-mediated recruitment and activation of Syk.

ICAM1 SYK

2.76e-053106221171946
Pubmed

Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.

CD247 MTOR

2.76e-053106219201859
Pubmed

BAIAP2L2 promotes the progression of gastric cancer via AKT/mTOR and Wnt3a/β-catenin signaling pathways.

MTOR BAIAP2L2

2.76e-053106232570120
Pubmed

NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease.

ICAM1 NOD1

2.76e-053106216741608
Pubmed

Inhibition of mammalian target of rapamycin is required for optimal antitumor effect of HER2 inhibitors against HER2-overexpressing cancer cells.

ERBB2 MTOR

2.76e-053106219934303
Pubmed

Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors.

ERBB2 MTOR

2.76e-053106224323026
Pubmed

Combination of blockade of endothelin signalling and compensation of IGF1 expression protects the retina from degeneration.

PROM1 MTOR

2.76e-053106238252153
Pubmed

Clinical implications of HER-2/neu overexpression and proteolytic activity imbalance in breast cancer.

ERBB2 TIMP2

2.76e-053106217613170
Pubmed

A biosensor capable of identifying low quantities of breast cancer cells by electrical impedance spectroscopy.

ERBB2 EPCAM

2.76e-053106231015522
Pubmed

CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer.

MUC16 CLIC1

2.76e-053106230282979
Pubmed

HER2 expression and its clinicopathological features in resectable gastric cancer.

ERBB2 MME

2.76e-053106222410801
Pubmed

Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.

PROM1 EPCAM

2.76e-053106227557490
Pubmed

Sh3tc2 deficiency affects neuregulin-1/ErbB signaling.

ERBB2 EEA1

2.76e-053106223553667
Pubmed

MicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2).

ERBB2 MTOR

2.76e-053106230147110
Pubmed

Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients.

LGR4 EPCAM

2.76e-053106235008827
Pubmed

Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.

ERBB2 FLT1

2.76e-053106226124351
Pubmed

Immunohistochemical comparison of MUC1, CA125, and Her2Neu in invasive micropapillary carcinoma of the urinary tract and typical invasive urothelial carcinoma with retraction artifact.

ERBB2 MUC16

2.76e-053106219270645
Pubmed

Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer.

ERBB2 MTOR

2.76e-053106228468774
Pubmed

Inhibition of Akt (ser473) phosphorylation and rapamycin-resistant cell growth by knockdown of mammalian target of rapamycin with small interfering RNA in vascular endothelial growth factor receptor-1-targeting vector.

FLT1 MTOR

2.76e-053106221532145
Pubmed

Prognostic value of CD133+ CD54+ CD44+ circulating tumor cells in colorectal cancer with liver metastasis.

ICAM1 PROM1

2.76e-053106229105339
Pubmed

Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.

PROM1 EPCAM

2.76e-053106226141860
Pubmed

Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation.

FLT1 SYK

2.76e-053106221642504
Pubmed

WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.

DIDO1 MCM6 NOL10 TBC1D10B HLTF EXOC2 EEA1 XRCC6

2.90e-05394106827248496
Pubmed

∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.

CLTCL1 MYH13 ICAM1 MCM6 THADA SLC25A12 CLIC1 MTOR SEC16A EPCAM

2.97e-056471061026618866
Pubmed

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.

BTAF1 MTOR SEC16A EIF5B TTC17 XRCC6

3.75e-05202106633005030
Pubmed

Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.

ERBB2 OBSCN GCLC MTOR SEC16A TTC17 XRCC6

4.23e-05304106732235678
Pubmed

A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.

ERBB2 MUC16 BTAF1 STIL RCC2 PTPRB SEC16A EIF5B

4.55e-05420106828065597
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

AIMP2 DYNC2H1 MCM6 MAPRE3 THADA SBNO1 MTOR SEC16A EIF5B EXOC2 EEA1 TMEM231 PIH1D1 WDR48

4.93e-0513211061427173435
Pubmed

Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.

AIMP2 OBSCN MCM6 TRAPPC12 DNAH5 KDM6A

5.17e-05214106622199357
Pubmed

Neonatal Wnt-dependent Lgr5 positive stem cells are essential for uterine gland development.

LGR4 PROM1 EPCAM

5.32e-0524106331772170
Pubmed

Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer.

ERBB2 MUC16

5.50e-054106214566828
Pubmed

A cancer/testis antigen, NY-SAR-35, induces EpCAM, CD44, and CD133, and activates ERK in HEK293 cells.

PROM1 EPCAM

5.50e-054106228126340
Pubmed

CD81 controls sustained T cell activation signaling and defines the maturation stages of cognate immunological synapses.

ICAM1 CD247

5.50e-054106223858057
Pubmed

Linkage analysis demonstrates that the Timp-2 locus is on mouse chromosome 11.

ERBB2 TIMP2

5.50e-05410621427919
Pubmed

Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.

ERBB2 XRCC6

5.50e-054106219906305
Pubmed

Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia.

DYNC2H1 OBSCN

5.50e-054106226147384
Pubmed

Morphological and phenotypical features of ovarian metastases in breast cancer patients.

ERBB2 EPCAM

5.50e-054106228327103
Pubmed

Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice.

ERBB2 MTOR

5.50e-054106218974106
Pubmed

Activation of Syk by protein kinase C-delta regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via tyrosine phosphorylation of RelA/p65.

ICAM1 SYK

5.50e-054106218362147
Pubmed

A TORC2-Akt Feed-Forward Topology Underlies HER3 Resiliency in HER2-Amplified Cancers.

ERBB2 MTOR

5.50e-054106226438156
Pubmed

Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cells.

ICAM1 MTOR

5.50e-054106220459645
Pubmed

Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.

PROM1 EPCAM

5.50e-054106228216140
Pubmed

VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation.

ICAM1 PROM1

5.50e-054106216809613
Pubmed

CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence.

ICAM1 EPCAM

5.50e-054106236737794
Pubmed

RIM-BP3 is a manchette-associated protein essential for spermiogenesis.

RIMBP3C RIMBP3B

5.50e-054106219091768
Pubmed

Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.

ERBB2 MTOR

5.50e-054106218807177
Pubmed

Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater.

PROM1 EPCAM

5.50e-054106222130902
Pubmed

Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells.

ERBB2 MTOR

5.50e-054106217631500
Pubmed

Circulating endothelial cell number and markers of endothelial dysfunction in previously preeclamptic women.

FLT1 ICAM1

5.50e-054106226116870
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

AIMP2 MYH13 ICAM1 PCDHAC2 DIDO1 NOL10 ADD3 TBC1D10B SARS2 CLIC1 SEC16A EEA1 XRCC6 PCM1

7.33e-0513711061436244648
Pubmed

ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.

ERBB2 STIM2 HTRA1 NAGLU LGR4 RTN3 PLXND1 ADGRE2 LIFR THADA CLIC1 TTC17 TMEM231

7.57e-0512011061335696571
Pubmed

DEPTOR stabilizes ErbB2 to promote the proliferation and survival of ErbB2-positive breast cancer cells.

ERBB2 MTOR

9.15e-055106233995662
Pubmed

TonEBP Regulates PCNA Polyubiquitination in Response to DNA Damage through Interaction with SHPRH and USP1.

HLTF WDR48

9.15e-055106231376680
Pubmed

STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice.

MTOR STRADA

9.15e-055106220424326
Pubmed

Structure and evolution of RIM-BP genes: identification of a novel family member.

RIMBP3C RIMBP3B

9.15e-055106217855024
Pubmed

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.

PROM1 EPCAM

9.15e-055106220606680
Pubmed

The road to chromatin - nuclear entry of retroviruses.

NUP98 XRCC6

9.15e-055106217304248
Pubmed

TRIM37 deficiency induces autophagy through deregulating the MTORC1-TFEB axis.

MTOR TRIM37

9.15e-055106229940807
Pubmed

SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.

ERBB2 AIMP2 MCM6 RCC2 SARS2 CLIC1 EIF5B EEA1 FH

1.04e-04607106939147351
Pubmed

Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.

HTRA1 DLGAP4 STIL LIFR SLC25A12

1.06e-04152106534299191
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

TBC1D19 NUP98 DIDO1 BTAF1 PTPRB SEC16A EEA1

1.22e-04360106733111431
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

CLTCL1 ASCC1 BTAF1 RCC2 LIFR THADA CLIC1 MTOR HLTF EIF5B RARS2 EXOC2 XRCC6 PCM1

1.23e-0414401061430833792
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

GABRG2 STIM2 CLTCL1 MYH13 PTBP2 PCDHGA2 NUP98 SLC25A12 KRT71 SBNO1 GCLC EIF5B EEA1 XRCC6

1.25e-0414421061435575683
InteractionCSTPP1 interactions

TBC1D19 STIL EEA1 FH TRIM37 PCM1

3.87e-06811046int:CSTPP1
GeneFamilyADAM metallopeptidase domain containing|CD molecules

ERBB2 ICAM1 ADGRE2 LIFR PROM1 CD247 MME EPCAM

1.24e-04394698471
GeneFamilyFibronectin type III domain containing

MYBPH OBSCN LIFR PTPRB USH2A

3.63e-04160695555
CoexpressionGSE1432_1H_VS_6H_IFNG_MICROGLIA_UP

ECM2 NUP98 LGR4 RTN3 MCM6 PLXND1 STIL GFOD1

1.59e-062001068M3409
CoexpressionJOHNSTONE_PARVB_TARGETS_3_UP

HTRA1 ICAM1 NAGLU LGR4 DIDO1 ADD3 TIMP2 SCG2 SEC16A EPCAM

1.06e-0543310610M2240
CoexpressionGSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP

ERBB2 DYNC2H1 GFOD1 SLC35D3 EEA1 ARHGAP20 PIH1D1

1.75e-052001067M9166
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TSHZ2 MUC16 PROM1 GCLC TMEM231 CFAP44 DNAH5 PCM1

2.55e-081981068d0ecace1fad24ce50b0935036fabb07e6c9e372d
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 MUC16 PROM1 TTLL10 TMEM231 CFAP44 DNAH5

1.66e-07169106714aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCellNS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

TSHZ2 DYNC2H1 MAPRE3 TTLL10 TMEM231 CFAP44 DNAH5

4.08e-071931067ea345d34440b25f65358a53dc72831998d1c3620
ToppCellP15-Endothelial-large_vessel_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FLT1 HTRA1 TSHZ2 ICAM1 PLXND1 PTPRB SMPDL3A

4.08e-0719310675f9a7cd5f8eb9ac294cdb50518fedf872f3f78f5
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 MUC16 PROM1 TTLL10 TMEM231 CFAP44 DNAH5

4.23e-0719410674a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCellCOVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class

DYNC2H1 MUC16 PROM1 TTLL10 TMEM231 CFAP44 DNAH5

4.53e-071961067de7aa31354b019d7321a8ef965d59ce2e8b89276
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 MUC16 PROM1 TMEM231 CFAP44 DNAH5 PCM1

4.69e-07197106791637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 MUC16 PROM1 TMEM231 CFAP44 DNAH5 PCM1

4.69e-07197106722c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 MUC16 PROM1 TMEM231 CFAP44 DNAH5 PCM1

4.69e-0719710673bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 MUC16 PROM1 TMEM231 CFAP44 DNAH5 PCM1

4.69e-07197106787db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCellASK428-Endothelial-Endothelium|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq

FLT1 LIFR PTPRB TTC17

2.76e-06411064a72d926de3dc9e420b80764af88002e436517790
ToppCell3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 PROM1 TTLL10 TMEM231 CFAP44 DNAH5

3.68e-061731066c3762655caa79ac4879876f470d32578a3c93b01
ToppCelldroplet-Lung-21m-Epithelial-airway_epithelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

C12orf56 SLC35D3 CFAP44 DNAH5 EPCAM JHY

3.68e-061731066a809be2630d2b91b53b82b5e2bb99e05524597c1
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 MUC16 TTLL10 CFAP44 SCIN DNAH5

4.06e-061761066dee780cfa85234a7cd7bf440b66b84cec959893e
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 PROM1 TMEM231 CFAP44 DNAH5 PCM1

4.62e-0618010661f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCelldroplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 HTRA1 TSHZ2 ADD3 PTPRB SCG2

4.62e-061801066dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 PROM1 TTLL10 TMEM231 CFAP44 DNAH5

4.62e-06180106692fb01b91261b3103454924cde56add337b41844
ToppCelldroplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 HTRA1 TSHZ2 ADD3 PTPRB SCG2

4.62e-061801066423454e3390080ae03bb3cbb267255ebfe4df080
ToppCellCiliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

DYNC2H1 MUC16 PROM1 TTLL10 TMEM231 DNAH5

5.41e-061851066f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

ZNF274 ZNF329 HEATR5A TMEM231 ARHGAP20 CFAP44

5.41e-0618510661b8e3ddb91797f84e4b15d2457b0c008e5be50db
ToppCell343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

ZNF274 ZNF329 HEATR5A TMEM231 ARHGAP20 CFAP44

5.41e-06185106602cbf492bc40abebaa93a3a208888afae72fbe06
ToppCelldroplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 TSHZ2 DENND2D PLXND1 PTPRB TRIM37

5.41e-061851066bdd2e6cb20294b39a9d856004bf57ba69cf877e2
ToppCellP15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FLT1 HTRA1 ICAM1 PLXND1 PTPRB SMPDL3A

5.93e-06188106650b27fc12347ca16bd62333baf345c83cb422a8f
ToppCelldroplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYBPH FLT1 PLXND1 ADD3 PTPRB TRIM37

5.93e-0618810660aa8747c2931b0c91f6d78bb2db8fd8ede6dd559
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 C12orf56 NOD1 PTPRB GFOD1 FAM124B

5.93e-061881066c2c51c6526defe2600302901159b8abbb58d7595
ToppCellP28-Endothelial-large_vessel_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FLT1 ICAM1 PLXND1 PTPRB CLIC1 SMPDL3A

5.93e-061881066263169029293e005bcffd87db20221fdd2d3917e
ToppCelldroplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYBPH FLT1 PLXND1 ADD3 PTPRB TRIM37

6.30e-061901066a08c5929b05a4969852e351a93c4e4deb4c8d5b6
ToppCelldroplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYBPH FLT1 PLXND1 ADD3 PTPRB TRIM37

6.30e-06190106625525fee1da8a808034d9c916159fd0b6b26bce8
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ERBB2 STIM2 POU3F4 SYK SCIN EPCAM

6.30e-061901066078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

AIMP2 TSHZ2 MCM6 DENND2D CD247 POLR3E

6.49e-0619110669bb6a6b88f351217455765ba07a6acf11fda98f4
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

NUP98 POLR3E MME KDM6A PCM1 RBM38

6.49e-0619110661ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ERBB2 STIM2 POU3F4 SYK SCIN EPCAM

6.49e-0619110660a0719a0a49ae0099d61e22585ac74c10c24b4a2
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

AIMP2 TSHZ2 MCM6 DENND2D CD247 POLR3E

6.69e-0619210661c0ce299cee9ab5cdea256f3e8c1e5598577a8b6
ToppCellmild-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PILRA RTN3 ADGRE2 MMP25 TIMP2 MME

6.69e-0619210664cd8f572e067bf5fe22f62fa868d7d332f097a8c
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 PLXND1 PTPRB TIMP2 GFOD1 SCIN

6.89e-061931066cc355b2ed6510619cad969ae074126d7c8db784d
ToppCell5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLT1 TSHZ2 ICAM1 PLXND1 LIFR PTPRB

6.89e-061931066c0973a2c97deb7176c2f617c8760a55f7edc9839
ToppCellmoderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DYNC2H1 STIL RCC2 TMEM231 EPCAM PCM1

7.09e-0619410665dffa578149104dda33774361e9e77b227b5f1ce
ToppCellcontrol-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PILRA RTN3 ADGRE2 MMP25 TIMP2 MME

7.09e-061941066c2ae2ea848d78725455dcb6be9f1d8933745fa80
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ERBB2 STIM2 POU3F4 SYK SCIN EPCAM

7.09e-061941066d602a0cdb69cd5a3e9ef61ddbab8d920557dd73e
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ERBB2 RTN3 POU3F4 SYK SCIN EPCAM

7.09e-061941066158dc393639e69aecfb014f6106797214ea05fe5
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 PROM1 TTLL10 TMEM231 CFAP44 DNAH5

7.30e-061951066581b04220587e1d5198b1abd6965965ace7803e7
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 PROM1 TTLL10 TMEM231 CFAP44 DNAH5

7.30e-06195106693b1559382a12cfb158aa5fac7386e38b4f87989
ToppCell3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 PROM1 TTLL10 TMEM231 CFAP44 DNAH5

7.30e-06195106679dc031258579ea328181dda33710dd897f1064a
ToppCellmoderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DYNC2H1 MAPRE3 TTLL10 TMEM231 CFAP44 DNAH5

7.30e-0619510663486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCellmoderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DYNC2H1 MAPRE3 TTLL10 TMEM231 CFAP44 DNAH5

7.30e-061951066e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 MUC16 PROM1 TTLL10 CFAP44 DNAH5

7.30e-0619510669651ee03738226ee10e901f8b9ec6a417eb9c301
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

STIM2 ADD3 CD247 POLR3E PCM1 RBM38

7.30e-061951066ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCell3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLT1 ICAM1 PLXND1 PTPRB GFOD1 FAM124B

7.74e-06197106698e34e8612f111bb667a574de1faaa785d318ca4
ToppCellPSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DYNC2H1 MAPRE3 TTLL10 TMEM231 CFAP44 DNAH5

7.74e-0619710666865f4831eb23794fb88a8649d48d497bbae3f44
ToppCellNS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DYNC2H1 PROM1 TTLL10 TMEM231 CFAP44 DNAH5

7.74e-06197106671fea4aa6ce96c7693fa94792d08770622873850
ToppCellsevere-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PILRA RTN3 ADGRE2 MMP25 TIMP2 MME

7.74e-0619710663b71e523d8a68f131def17233385df371db70db5
ToppCellcontrol-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DYNC2H1 PROM1 TTLL10 TMEM231 CFAP44 DNAH5

7.74e-061971066e453d085182364ca347cbcc9dc995c62c3353016
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

STIM2 MUC16 PROM1 GCLC CFAP44 SCIN

7.74e-0619710665c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCellCOVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class

MUC16 PROM1 TTLL10 TMEM231 DNAH5 EPCAM

7.74e-06197106618fd7344628a87d5c7ef5efb66e260a4136245bf
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

TSHZ2 ADD3 LIFR SMPDL3A MME ARHGAP20

7.74e-0619710660034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCellcontrol-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DYNC2H1 PROM1 TTLL10 TMEM231 CFAP44 DNAH5

7.74e-061971066d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

TSHZ2 ADD3 LIFR SMPDL3A MME ARHGAP20

7.74e-06197106611a4c417f035e554431a8f03be13b5eefa3530c0
ToppCellmild-Myeloid|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PILRA RTN3 ADGRE2 MMP25 TIMP2 MME

7.97e-061981066908746384e10c6b833bb3bc124045d7b0bfd73b5
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_macrophage|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

FNIP2 PILRA ADGRE2 TIMP2 SMPDL3A SCIN

7.97e-061981066c08018f099a381a66993cb60288954a6e47f105f
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

FNIP2 PILRA ADGRE2 TIMP2 SMPDL3A SCIN

7.97e-06198106627cc7f786fb8cb230589d762a4e51b46265c1f19
ToppCellFetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type.

MYT1L GABRG2 DLGAP4 RTN3 MAPRE3 ZNF844

8.20e-061991066b2508bf591720830e8e3494b1337aab14539956d
ToppCellControl_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type

FLT1 STIM2 ADD3 LIFR PTPRB FAM124B

8.44e-0620010663b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCellBronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

STIM2 TSHZ2 MUC16 PROM1 DNAH5 EPCAM

8.44e-062001066f5bc7d30aa03dd0f95eb64255bd1a2543be8d327
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

FLT1 STIM2 ADD3 LIFR PTPRB FAM124B

8.44e-062001066b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCellParenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

HTRA1 TSHZ2 ECM2 NAGLU OBSCN ZNF844

8.44e-0620010668a4c210a3130f7baedf15ecbc0f4903b97da0352
ToppCellCOVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type

MYT1L FLT1 MUC16 PTPRB USH2A

2.07e-05139106564c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCellBronchial_Biopsy-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

NUP98 MMP25 TIMP2 MME BAIAP2L2

3.27e-051531065e9d6b4e895ddb8d6e6c8b043da591ec11365e124
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 ADGRE2 PTPRB CLIC1 TRIM37

3.82e-051581065ba9998cbf786c515d30fe42de02c7a246db1b6f9
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 ADGRE2 PTPRB CLIC1 TRIM37

3.82e-051581065a2efcc184ef13d81373e3690253ba35f6be09c5f
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 ADGRE2 PTPRB CLIC1 TRIM37

3.82e-051581065e52eff2bd1e7e0ce9c278ed5109802865e0fe69c
ToppCellAdult-Endothelial-endothelial_cell_of_vein-D122|Adult / Lineage, Cell type, age group and donor

FLT1 LIFR PTPRB GFOD1 FAM124B

4.05e-0516010650cfe130606af433b2aa90e0a20b6c44659dd6fd4
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.

MYT1L GABRG2 SGSM1 SCG2 DNAH5

4.69e-0516510659795ce31689bc63f5a2d68725ef00b23a90c3846
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MMP25 CD247 SARS2 GFOD1 TTLL10

5.41e-051701065aaf29c2d4de172d366cbfc863bc741941667dde1
ToppCellE16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FLT1 TSHZ2 ECM2 OBSCN PTPRB

5.41e-051701065af8b56555cbd5a1016ab9ec2ce88225c58c89648
ToppCell367C-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

AGBL3 PTPRB GFOD1 SMPDL3A ZNF844

5.56e-051711065943fbca8a6ac04052a2a85aca7b21a3461cd96f7
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HTRA1 KRT71 TIMP2 SCG2 RIMBP3B

5.71e-05172106535e961c88bfe79046533396912cedf00ca81db7b
ToppCellCiliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

DYNC2H1 MUC16 TMEM231 CFAP44 DNAH5

5.71e-051721065187ae91148d293537afc77e10da2b64302322224
ToppCellE12.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FLT1 ICAM1 PLXND1 PTPRB FAM124B

5.71e-051721065ba99688e9f46671deccf824b1e77c6db0742d7df
ToppCellE12.5-Endothelial-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FLT1 ICAM1 PLXND1 PTPRB FAM124B

5.71e-0517210652136170f6e1204734cec7dbf7b32e7d5179b92b5
ToppCellE15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FLT1 HTRA1 ECM2 PTPRB SMPDL3A

5.87e-051731065b0ff9808e38cb64a734ced498cd0546728746cd5
ToppCelldroplet-Lung-nan-21m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

C12orf56 TTLL10 CFAP44 DNAH5 JHY

6.20e-0517510653ed22ea41810e73c02db4f2d03745e4ce7e43bb1
ToppCelldroplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FLT1 SGSM1 PLXND1 CD247 PTPRB

6.20e-0517510657be76d39e1a4f4ac709672cd2d409a2523a083ce
ToppCelldroplet-Lung-nan-21m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

C12orf56 TTLL10 CFAP44 DNAH5 JHY

6.20e-0517510658fb1e5f6aa68274adf322401db8c7b80e8c554d7
ToppCellNS-critical-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DYNC2H1 PROM1 TMEM231 CFAP44 EPCAM

6.37e-051761065b794275fdd757b8fa2108e3c867f23da2649146d
ToppCelldroplet-Limb_Muscle-nan-21m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYBPH AGBL3 THADA MTOR EXOC2

6.55e-051771065291231b1520c135e92739e201495fe1935efa927
ToppCelldroplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

C12orf56 SLC35D3 CFAP44 DNAH5 JHY

6.55e-051771065d947ba38db1772fc5fdcdc211f7511c4aa699dee
ToppCelldroplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

C12orf56 SLC35D3 CFAP44 DNAH5 JHY

6.55e-051771065d5640f0097878f0dac671e51dc51310278bb2682
ToppCellfacs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FLT1 LIFR PTPRB ARHGAP20 TRIM37

6.72e-051781065ebfae386a518ea33911ba3ff40464c94d18ef695
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FLT1 HTRA1 TSHZ2 TIMP2 SCG2

6.72e-0517810653c973aac16988e88f5677d3d695dd772ccfd6570
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 C12orf56 PLXND1 PTPRB GFOD1

6.72e-0517810655f779a66aa42d1d8e8af17b4a08d5dcc733efd4c
ToppCellfacs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FLT1 LIFR PTPRB ARHGAP20 TRIM37

6.72e-051781065ccd37575b60102f5e647c01546e8ff8fec638bd7
ToppCellfacs-Lung-18m-Endothelial-venous_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FLT1 LIFR PTPRB ARHGAP20 TRIM37

6.72e-05178106587b04753650e45f12299c8456fb980d6c0d5961c
ToppCellEndothelial|World / shred by cell class for turbinate

FLT1 PLXND1 MAPRE3 PTPRB MME

6.90e-051791065052b2681974be00efb8503fa4e2c85d91d5ebd06
ToppCell5'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLT1 ICAM1 PLXND1 PTPRB FAM124B

7.09e-051801065af7c4b9f1a0ddd894085cf93c29a6d253a7d077c
ToppCell5'-GW_trimst-1-SmallIntestine-Endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLT1 ICAM1 PLXND1 PTPRB FAM124B

7.09e-051801065e35e9159f5cd9ec905b3b6e27d938158aeb9c51c
ToppCellfacs-Lung-EPCAM-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 ADGRE2 LIFR PTPRB FAM124B

7.09e-051801065082c6116e0bbba8d9a3a82d14af55bdc8990c8c0
ToppCellfacs-Lung-EPCAM-18m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 ADGRE2 LIFR PTPRB FAM124B

7.09e-05180106553043d764fad9ac33ee40e356e562e759931adef
ToppCell5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLT1 ICAM1 PLXND1 PTPRB FAM124B

7.27e-0518110659bfd93cf053beaee806cacdffd7abef02f94aec6
ToppCell5'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLT1 ICAM1 PLXND1 PTPRB FAM124B

7.27e-0518110657d7d1edeae4e0ebe40b324d1231cd26e27ba9d42
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FLT1 TIMP2 SCG2 MME GRIN3A

7.27e-0518110657846c7b33d1b89364c5a704edaa86520db731c89
DrugMoxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; PC3; HT_HG-U133A

ICAM1 NUP98 LGR4 THADA SMPDL3A TTC17 EEA1 TMEM231 KDM6A

3.33e-0719910497255_DN
DrugTerfenadine [50679-08-8]; Down 200; 8.4uM; HL60; HG-U133A

CLTCL1 NUP98 LGR4 DIDO1 NOD1 SBNO1 EIF5B PCM1

2.54e-0618910481381_DN
Diseaserenal cell carcinoma (is_marker_for)

ERBB2 FLT1 TIMP2 MTOR KDM6A

8.85e-051281035DOID:4450 (is_marker_for)
Diseasedilated cardiomyopathy (implicated_via_orthology)

ERBB2 STIM2 MYH13 ICAM1

1.81e-04801034DOID:12930 (implicated_via_orthology)
Diseaseductal carcinoma in situ (is_marker_for)

ERBB2 FLT1 TIMP2

3.45e-04391033DOID:0060074 (is_marker_for)
DiseaseCiliopathies

DYNC2H1 TMEM231 DNAH5 USH2A

6.09e-041101034C4277690
DiseaseMedulloblastoma

ERBB2 STRADA KDM6A

7.19e-04501033C0025149
Diseaseneuroblastoma

MYH13 MMP25 KRT71 DNAH5

7.43e-041161034EFO_0000621
Diseaseretinopathy of prematurity (biomarker_via_orthology)

FLT1 ICAM1

7.78e-04121032DOID:13025 (biomarker_via_orthology)
Diseasethyroid gland carcinoma (is_marker_for)

FLT1 PTPRB

7.78e-04121032DOID:3963 (is_marker_for)
DiseasePrecursor T-Cell Lymphoblastic Leukemia-Lymphoma

STIL MTOR KDM6A

8.52e-04531033C1961099
Diseasesuperior frontal gyrus grey matter volume measurement

TBC1D19 STIM2

1.07e-03141032EFO_0006516
Diseasevascular dementia (biomarker_via_orthology)

FLT1 MTOR

1.07e-03141032DOID:8725 (biomarker_via_orthology)
Diseasehypertension (implicated_via_orthology)

MYBPH ADD3 MTOR MME

1.07e-031281034DOID:10763 (implicated_via_orthology)
DiseaseNeoplasm of uncertain or unknown behavior of bladder

MTOR KDM6A

1.23e-03151032C0496930
DiseaseBenign neoplasm of bladder

MTOR KDM6A

1.23e-03151032C0154017
DiseaseCarcinoma in situ of bladder

MTOR KDM6A

1.23e-03151032C0154091
Diseaseovarian neoplasm

ERBB2 MUC16 MTOR EPCAM

1.27e-031341034C0919267
DiseaseMalignant neoplasm of ovary

ERBB2 MUC16 MTOR EPCAM

1.38e-031371034C1140680
DiseaseMalignant lymphoma, lymphocytic, intermediate differentiation, diffuse

MTOR SYK

1.40e-03161032C0334634
DiseaseKuhnt-Junius degeneration (is_implicated_in)

FLT1 HTRA1

1.59e-03171032DOID:10873 (is_implicated_in)
DiseaseUremia

FLT1 ICAM1

1.59e-03171032C0041948
DiseaseCarcinoma of bladder

MTOR KDM6A

1.78e-03181032C0699885
DiseaseHemangiosarcoma

FLT1 PTPRB

1.78e-03181032C0018923
DiseaseConventional (Clear Cell) Renal Cell Carcinoma

ERBB2 FLT1 MTOR KDM6A

1.83e-031481034C0279702
DiseaseS-6-hydroxywarfarin measurement

NOL10 BTAF1 PROM1 EXOC2 GRIN3A SCIN

1.87e-033681036EFO_0803326
Diseaseportal hypertension (implicated_via_orthology)

TIMP2 MTOR

1.99e-03191032DOID:10762 (implicated_via_orthology)
DiseaseColonic Neoplasms

ERBB2 ICAM1 PROM1 MTOR

2.02e-031521034C0009375
Diseasepentachlorophenol measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022071
Diseaseparathion measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022070
Diseasepotassium chromate measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022072
Diseasemercuric chloride measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022068
Diseaseheptachlor epoxide measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022067
Diseasemethoxychlor measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022069
Disease4,6-dinitro-o-cresol measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022053
Disease2,4,5-trichlorophenol measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022052
Diseaseazinphos methyl measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022055
Diseasealdrin measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022054
Diseasedicofol measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022060
Diseasedisulfoton measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022062
Diseasedieldrin measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022061
Diseaseendrin measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022064
Diseaseendosulfan measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022063
Diseaseheptachlor measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022066
Diseaseethion measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022065
Diseasechlorpyrifos measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022057
Diseasecadmium chloride measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022056
Diseasediazinon measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022059
Diseasedibutyl phthalate measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0022058
Diseaseenvironmental exposure measurement

TSHZ2 MUC16 USH2A

2.15e-03731033EFO_0008360
DiseaseDDT metabolite measurement

TSHZ2 MUC16 USH2A

2.24e-03741033EFO_0007886
DiseaseMalignant tumor of colon

ERBB2 ICAM1 PROM1 MTOR

2.37e-031591034C0007102
Diseaseotitis media (implicated_via_orthology)

NAGLU DNAH5

2.66e-03221032DOID:10754 (implicated_via_orthology)
DiseaseBronchiectasis

ICAM1 DNAH5

2.66e-03221032C0006267
DiseaseSjogren's syndrome (is_marker_for)

ICAM1 MUC16

3.17e-03241032DOID:12894 (is_marker_for)
Diseasephosphatidylethanolamine measurement

GABRG2 SGSM1 STRADA USH2A

3.21e-031731034EFO_0010228

Protein segments in the cluster

PeptideGeneStartEntry
NYALAVLDNGDPLNN

ERBB2

111

P04626
RAKPEGALQNNDGLY

EPCAM

81

P16422
DEQANKNDGQPTLYL

AGBL3

981

Q8NEM8
QDLGRDYKPGLANNT

ADGRE2

286

Q9UHX3
QNRYDLKTAGPQSQL

ADD3

511

Q9UEY8
IDGRNYRKNPVQEQT

ASCC1

11

Q8N9N2
KNGAIRVYVLNQNDP

CFAP44

826

Q96MT7
AQIKRNLSYGDNSDP

DLGAP4

756

Q9Y2H0
PEGNILDYANKQLAG

NAGLU

651

P54802
EVPKQQAAYRNLGQN

RCC2

121

Q9P258
NPIIDGRKANVNLAY

RBM38

96

Q9H0Z9
DVGENALQKYALNPN

PCDHGA2

161

Q9Y5H1
EENKQLRRAGCPYQA

RIMBP3B

396

A6NNM3
EENKQLRRAGCPYQA

RIMBP3C

396

A6NJZ7
GIPNDTRKLYLDANQ

LRRC3C

76

A6NJW4
DRDGLQQLYGKAPQT

MMP25

271

Q9NPA2
PGTTNYQRNKRNIED

MUC16

14341

Q8WXI7
RKKEGEYNVQQQCPG

MUC16

14481

Q8WXI7
INGYNEDINQESAPK

MCM6

696

Q14566
NIFLYNPDGNLQERA

PTPRB

1116

P23467
IALLPENRGKNRYNN

PTPRB

1721

P23467
EDYQANRKGPQNQVG

NUP98

206

P52948
GANNRQQPIEDKYSD

JHY

111

Q6NUN7
AELGPLNKYLQQNRH

SYK

451

P43405
LEKQTNNPGIRLFQY

SMPDL3A

326

Q92484
QYLQKSLEADPNSGQ

KDM6A

271

O15550
EQFNPALENLVYLGN

BAIAP2L2

21

Q6UXY1
ADENYRPLAKTRQQN

PCM1

961

Q15154
TDNYNKILQLDPGQG

PLXND1

121

Q9Y4D7
LPLNIERNIQKGDYD

EXOC2

286

Q96KP1
QLGLNDENDRYVPNL

HERC4

221

Q5GLZ8
ERGLEPLKNNNYRIS

GCLC

311

P48506
GYPDDIVSNDNKLNN

MME

481

P08473
DNNNLNDYGVRELQP

NOD1

711

Q9Y239
DLNYNNLGEFPQAIK

LGR4

231

Q9BXB1
GRYLNPLQTDAAENN

NOL10

166

Q9BSC4
FRNPQKLLQSDYLQG

POU3F4

31

P49335
AVDNLNRVEGLLPYN

GRIN3A

131

Q8TCU5
NNVLRPGDKYSLRQE

OBSCN

3221

Q5VST9
RSPAELYKQANNNID

PCDHAC2

751

Q9Y5I4
YENIRNEGQNTDPKL

PILRA

246

Q9UKJ1
DNPKELEGYIQKLQN

DYNC2H1

666

Q8NCM8
YQGLQQQEAKPDGLV

EEA1

116

Q15075
YDGNKILLQVQLNPE

FAM124B

236

Q9H5Z6
LEQYQANVGAALRPA

HEATR5A

1311

Q86XA9
GQGQEDPNSLRHKYN

HTRA1

156

Q92743
PINAELRKYQQDGVN

BTAF1

1261

O14981
QRRKNPQEGLYNELQ

CD247

101

P20963
VNQDYGLDPKIANAI

FH

106

P07954
EYINQDPNLGKLNTN

FNIP2

191

Q9P278
NNLLEGYDNKLRPDI

GABRG2

71

P18507
QDKALGSAQYEDPRN

DIDO1

1691

Q9BTC0
QKRETPESRNQGQLY

ECM2

226

O94769
GKDYNPLLARQGQDV

MAPRE3

121

Q9UPY8
LPGNNRKVYELSNVQ

ICAM1

71

P05362
QRDPNNPYDKNAIKV

HLTF

86

Q14527
PDDGFYLSLQIRNNK

SBNO1

1201

A3KN83
NPNYCRSKGEQIALN

POLR3E

66

Q9NVU0
TYQFPKRENLLRGQQ

DENND2D

76

Q9H6A0
ERLNIPNLGIDDKYQ

DNAH5

576

Q8TE73
GYAGRQELPENLKIN

DNAH5

2086

Q8TE73
DLDKTAGYRPQANVN

LIFR

1021

P42702
NKLQQPEAAAGVLEY

MTOR

1421

P42345
DYLKQNQPLQEEGKT

ARHGAP20

741

Q9P2F6
PQRSYDILERNVKNG

RTN3

786

O95197
LANQDSGEVQQDPKY

SARS2

121

Q9NP81
QLFGYEEKLQSNPLQ

RARS2

186

Q5T160
EKPNGLVSQYQLSRN

USH2A

3706

O75445
RKQSNYEDLEAQPRG

SLC35D3

306

Q5M8T2
PEVLQQNLQGYDAKS

STRADA

246

Q7RTN6
LDLLANEGYLNPQND

TRIM37

381

O94972
NEGYLNPQNDTVILR

TRIM37

386

O94972
QPRDTNDYFNQAKIL

THADA

996

Q6YHU6
AREGLEDKYNLQLNP

PIH1D1

146

Q9NWS0
ALLQYGDPVNAQQAK

PTBP2

221

Q9UKA9
YGQRNSAPEQELLVQ

GFOD1

266

Q9NXC2
DDYLGGKPVQNRELQ

SCIN

86

Q9Y6U3
GKPVQNRELQGYESN

SCIN

91

Q9Y6U3
QGLNAALFYENKDPR

EIF5B

801

O60841
LVQQGYQSLNDIPDR

PROM1

356

O43490
YQGVSVPLQQKENGD

SCG2

81

P13521
EIQGNPKYRALSEQG

MYBPH

421

Q13203
FTRDQLPGDNNNNLY

SI

261

P14410
EQNKKQPRQDYQLGF

AIMP2

171

Q13155
AEGALPYNLAELQRQ

SLC25A12

296

O75746
NYATNVLQNPDLGLR

CLTCL1

336

P53675
AYIKNSNPALNDNLE

CLIC1

116

O00299
YLPESRDKNALQNQS

C12orf56

386

Q8IXR9
NIYVLQELDNPGAKR

XRCC6

101

P12956
PSDNQKIYQDLLGQV

STIL

931

Q15468
EKYNRNGVNALQLDP

WDR48

26

Q8TAF3
YQQVTKDAQGQPGLE

SEC16A

1041

O15027
ELQQYLGNPQESLDR

TRAPPC12

486

Q8WVT3
LPQYEKNFRDNNVKG

STIM2

151

Q9P246
AGPRNAQIQALYAED

ZNF274

121

Q96GC6
DSGNDIYGNPIKRIQ

TIMP2

56

P16035
NQQLDTKQPRQYFIG

MYH13

446

Q9UKX3
QYLSNSKELLEQNPG

TBC1D10B

371

Q4KMP7
LLYGKNNVLVQPRDD

SGSM1

256

Q2NKQ1
TEVLQNLGKDQYPQQ

TTC17

981

Q96AE7
NLGKDQYPQQSLEQI

TTC17

986

Q96AE7
QQAPKRAAGYAQEEQ

TSHZ2

6

Q9NRE2
NIEDQYKNPRNNLRS

ZNF844

51

Q08AG5
YVNGDLRLQQKQPLS

TMEM231

171

Q9H6L2
NKRNVNNRSYPEEGK

ZBED9

711

Q6R2W3
IVDNNLNSKNPGIYA

TOGARAM1

1576

Q9Y4F4
NVQQDGKDYIPINAI

FLT1

1161

P17948
VLINLRNPNYENGDS

TBC1D19

161

Q8N5T2
FREGEQLLYQLPNNK

TTLL10

206

Q6ZVT0
NENQRNLPGEKQYRC

ZNF329

191

Q86UD4
GQQRALPEGLYAQDK

ZSWIM4

476

Q9H7M6
NNCKNNLEPILEGYI

KRT71

171

Q3SY84
NQDRYQSPENKALLE

MYT1L

1161

Q9UL68